With AI, it's now possible for researchers to predict the three-dimensional structures of proteins directly from their ...

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

With AI, it's now possible for researchers to predict the three-dimensional structures of proteins directly from their amino-acid sequences.But what ...

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this ...

India’s semaglutide patent expiry has triggered a wave of cheaper generic versions of Ozempic, slashing prices and expanding access to diabetes and obesity treatment. With dozens of drugmakers ...

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...